Antonella Cammarota

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 14

Top Topics

Metastatic Renal Cell Carcinoma

Radiation Therapy

Top Venues

Therapeutic advances in medical oncology

Journal of hepatocellular carcinoma

Expert opinion on investigational drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David James Pinato, Lorenza Rimassa
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? Therapeutic advances in medical oncology 15 (2023)
Antonella Cammarota, Valentina Zanuso, Giulia Francesca Manfredi, Ravindhi Murphy, David James Pinato, Lorenza Rimassa
Immunotherapy in hepatocellular carcinoma: how will it reshape treatment sequencing? Therapeutic advances in medical oncology 15 (2023)
Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio, Tiziana Pressiani, Silvia Bozzarelli, Nicola Personeni, Lorenza Rimassa
The dual checkpoint blockade in unresectable hepatocellular carcinoma: opportunities emerging in clinical trials. Expert opinion on investigational drugs 31 (4) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights. Journal of hepatocellular carcinoma 9 (2022)
Nicola Personeni, Laura Giordano, Angelica Michelini, Antonio D'Alessio, Antonella Cammarota, Silvia Bozzarelli, Tiziana Pressiani, Maria Giuseppina Prete, Maria Teresa Sandri, Sabine Stioui, Luca Germagnoli, Armando Santoro, Lorenza Rimassa, Rossana Mineri
Implementing Pre-Therapeutic UGT1A1 Genotyping in Clinical Practice: A Real-Life Study. Journal of personalized medicine 12 (2) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Antonella Cammarota, Valentina Zanuso, Antonio D'Alessio, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials. Expert opinion on investigational drugs 31 (4) (2022)
Antonio D'Alessio, Maria Giuseppina Prete, Antonella Cammarota, Nicola Personeni, Lorenza Rimassa
The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges. Journal of hepatocellular carcinoma 8 (2021)
Antonella Cammarota, Antonio D'Alessio, Tiziana Pressiani, Lorenza Rimassa, Nicola Personeni
Systemic Treatment for Older Patients with Unresectable Hepatocellular Carcinoma. Drugs & aging 38 (7) (2021)
Antonio D'Alessio, Antonella Cammarota, Valentina Zanuso, Tiziana Pressiani, Nicola Personeni, Lorenza Rimassa
Atezolizumab plus bevacizumab for unresectable or metastatic hepatocellular carcinoma. Expert review of anticancer therapy 21 (9) (2021)
Maria Giuseppina Prete, Antonella Cammarota, Antonio D'Alessio, Valentina Zanuso, Lorenza Rimassa
Current options and future directions of systemic therapy for advanced biliary tract cancer. Exploration of targeted anti-tumor therapy 2 (5) (2021)